New Key Statistics Module, Z-Score and F-Score
SHSE:603676 Key Ratios
Market Cap ¥ M | 4,751.96 |
Enterprise Value ¥ M | 3,725.59 |
P/E(ttm) | 19.16 |
PE Ratio without NRI | 20.26 |
Forward PE Ratio | -- |
Price/Book | 3.20 |
Price/Sales | 3.97 |
Price/Free Cash Flow | 15.67 |
Price/Owner Earnings | 24.79 |
Payout Ratio % | 0.53 |
Revenue (TTM) ¥ M | 1,255.00 |
EPS (TTM) ¥ | 0.57 |
Beneish M-Score | -3.11 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 29.10 |
y-y EBITDA Growth Rate % | 9.60 |
EV-to-EBIT | 13.91 |
EV-to-EBITDA | 13.91 |
PEG | 0.70 |
Shares Outstanding M | 435.16 |
Net Margin (%) | 19.67 |
Operating Margin % | 15.48 |
Pre-tax Margin (%) | 21.31 |
Quick Ratio | 3.27 |
Current Ratio | 3.36 |
ROA % (ttm) | 13.27 |
ROE % (ttm) | 17.63 |
ROIC % (ttm) | 31.26 |
Dividend Yield % | 2.73 |
Altman Z-Score | 8.01 |
SHSE:603676 Number of Guru Trades
SHSE:603676 Volume of Guru Trades
Gurus Latest Trades with SHSE:603676
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:603676 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Xizang Weixinkang Pharmaceutical Co Ltd Insider Transactions
No Available Data